HBM Partners

HBM Partners is a Swiss healthcare investor managing USD 3 billion in assets. The firm focuses on venture, growth, and buy-out financings of private companies, as well as investments in public companies. Their primary sectors include biopharma, medtech, diagnostics, and healthcare in Europe, North America, India, China, and other emerging markets.

HBM Partners advises SIX-listed HBM Healthcare Investments Ltd and other specialized funds. Notable portfolio companies include Hookipa Pharma, iTeos Therapeutics, and Upstream Bio. The firm typically participates in Series B to Series D rounds, with investments ranging from $9 million to $208 million. HBM Partners offers expertise in healthcare investing and is regulated by FINMA, Switzerland's financial market supervisory authority.